Effect of the seasonally adjusted antihypertensive regimen on cardiovascular events in patients with essential hypertension

Ping-liang CAO,Xiao-shu CHENG,Nian-e LI,Qiong-zhen TANG,Zao-fang CHEN

DOI: https://doi.org/10.16439/j.cnki.1673-7245.2018.05.007

2018-01-01

Abstract:Objective To investigate the effect of the seasonally adjusted antihypertensive regimen on major cardiovascular events in patients with essential hypertension. Methods A total of 690essential hypertensive patients, receiving continuous antihypertensive treatment for at least three years, were included in this retrospective study between September 2005and September 2015. The patients were divided into three groups according to practical antihypertensive regimen for at least three years:the adjusted regimen group (182cases, increasing doses or classes of antihypertensive drugs in winter, and reducing doses or classes of antihypertensive drugs in summer for at least two months each year), the fixed regimen group(262cases, a fixed antihypertensive strategy)and the random regimen group(246cases, adjusting doses or classes of antihypertensive drugs temporarily). The primary end point was a composite of new or recurrent nonfatal myocardial infarction, new or recurrent nonfatal stroke, and death from cardiovascular diseases. Kaplan-Meier method was used to estimate the differences in survival curves among the three groups. Cox proportional hazards model was used to analyze the effect of the seasonally adjusted antihypertensive regimen on the risk of cardiovascular events. Results Office blood pressure in winter and blood pressure variability were significantly reduced in the adjusted regimen group than those in the other two groups(all P<0.05). A total of 148 patients reached the primary composite end point, including 123cases of stroke, 43cases of myocardial infarction and 39cases of death from cardiovascular diseases. The incidence rate of primary composite end point in the adjusted regimen group, the fixed regimen group and the random regimen group was 13. 19％, 22. 52％and 26. 42％, respectively, and there was a significant difference in the incidence rate among the three groups(χ2=11. 16, P=0. 004). Log-Rank test showed that the cumulative survival rate without primary composite end point in the adjusted regimen group was significantly higher than that in the other two groups(P<0. 001). Cox proportional hazards model showed that compared with the fixed regimen group, the relative risk of primary composite end point was decreased by 16％ (RR=0. 84, 95％CI 0.53-0.93, P=0.005), and the relative risk of stroke was decreased by 52％ (RR=0.48,95％ CI 0.26-0.88,P=0.015)in the adjusted regimen group. Conclusion The seasonally adjusted antihypertensive regimen could significantly reduce major cardiovascular events in patients with essential hypertension.